IVF vs. BTCY, DYNT, IONM, TTOO, GMVDF, AFIB, NMRD, UTRS, MOTS, and BVS
Should you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Biotricity (BTCY), Dynatronics (DYNT), Assure (IONM), T2 Biosystems (TTOO), G Medical Innovations (GMVDF), Acutus Medical (AFIB), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), and Bioventus (BVS). These companies are all part of the "surgical & medical instruments" industry.
INVO Fertility vs. Its Competitors
INVO Fertility (NASDAQ:IVF) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.
INVO Fertility has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.
In the previous week, Biotricity had 1 more articles in the media than INVO Fertility. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.
Biotricity has a net margin of -80.42% compared to INVO Fertility's net margin of -422.11%.
INVO Fertility has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.
12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 0.6% of INVO Fertility shares are owned by insiders. Comparatively, 10.1% of Biotricity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Biotricity beats INVO Fertility on 7 of the 12 factors compared between the two stocks.
Get INVO Fertility News Delivered to You Automatically
Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
INVO Fertility Competitors List
Related Companies and Tools
This page (NASDAQ:IVF) was last updated on 9/5/2025 by MarketBeat.com Staff
